Latest

What Next For Gold After The US Election?

With the change in US politics, are we in danger of seeing gold’s summer’s all-time highs threatened – and what…

Totally – very acceptable progress despite Covid-19

Mark Watson-Mitchell considers whether the AIM-listed healthcare services firm should totally be a part of your portfolio.

Reserves reassure Polymetal investors

FTSE 100 miner Polymetal International watched its share price climb by 2.51% after providing ore reserve estimates for the Pesherny…

Premier Foods up as Hovis sliced off

Shares in FTSE 250 Premier Foods rose 1.93% after it disposed of its share of Hovis Holdings for a £37…

James Fisher sinks as outlook worsens

The price of shares in James Fisher and Sons fell by 18.06% after it said that conditions remained challenging in…

It’s got to be Sleepy Joe – by a nose

Despite Mr Trump’s threats to litigate, Joe Biden will emerge as President-elect shortly. We should get used to a distinct…

Evil Knievil: A sporting bet

Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.

Longevity Market Watch

In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.

Small-cap round-up: featuring Medica, Smiths News, Sureserve and more…

In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the…

AVEVA H1 fails to reassure markets

The price of shares in AVEVA Group dropped by 7.24% after revenues for the six months ended 30th September fell…